Insider · CIK 0001589713

Magnani John L.

Reports to the SEC for 1 company · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001589713

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-11-11	CBIOCRESCENT BIOPHARMA, INC.P Purchase	SVP of Research, CSO	PPurchase	+45K sh	$1.17	+$52.7K	366,078
2022-03-09	CBIOCRESCENT BIOPHARMA, INC.S Sale	SVP of Research, CSO	SSale	−3,227 sh	$1.09	−$3,517.43	321,033
2022-01-21	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+100K sh	—	—	100,000
2022-01-21	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+25K sh	—	—	25,000
2021-01-20	CBIOCRESCENT BIOPHARMA, INC.A Award	SVP of Research, CSO	AAward	+34.5K sh	—	—	324,260
2021-01-20	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+69K sh	—	—	69,000
2020-01-22	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+120K sh	—	—	120,000
2020-01-06	CBIOCRESCENT BIOPHARMA, INC.M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	+107K sh	$1.12	+$120K	289,760
2020-01-06	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	−107K sh	—	—	0
2019-12-20	CBIOCRESCENT BIOPHARMA, INC.M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	+107K sh	$1.12	+$120K	182,777
2019-12-20	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	−107K sh	—	—	106,983
2019-01-17	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+100K sh	—	—	100,000
2018-10-18	CBIOCRESCENT BIOPHARMA, INC.S Sale	SVP of Research, CSO	SSale	−3,527 sh	$14.02	−$49.4K	75,793
2018-10-17	CBIOCRESCENT BIOPHARMA, INC.S Sale	SVP of Research, CSO	SSale	−7,273 sh	$14.00	−$102K	79,320
2018-10-16	CBIOCRESCENT BIOPHARMA, INC.S Sale	SVP of Research, CSO	SSale	−14.2K sh	$14.01	−$199K	86,593
2018-05-23	CBIOCRESCENT BIOPHARMA, INC.M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	+1,491 sh	$0.33	+$492.03	100,793
2018-05-23	CBIOCRESCENT BIOPHARMA, INC. · Warrant to Purchase Common Stock (right to buy)M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	−895 sh	—	—	0
2018-05-23	CBIOCRESCENT BIOPHARMA, INC. · Warrant to Purchase Common Stock (right to buy)M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	−596 sh	—	—	0
2017-05-10	CBIOCRESCENT BIOPHARMA, INC.M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	+8,928 sh	$1.12	+$9,999.36	99,302
2017-05-10	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)M Exercise/Conversion	SVP of Research, CSO	MExercise/Conversion	−8,928 sh	—	—	213,967
2017-01-04	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+75K sh	—	—	75,000
2016-01-07	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+71K sh	—	—	71,000
2015-01-08	CBIOCRESCENT BIOPHARMA, INC. · Employee Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+71K sh	—	—	71,000
2014-01-15	CBIOCRESCENT BIOPHARMA, INC.C Conversion	SVP of Research, CSO	CConversion	−9,969 sh	—	—	90,374
2014-01-15	CBIOCRESCENT BIOPHARMA, INC. · Series A-1 Preferred StockC Conversion	SVP of Research, CSO	CConversion	−32.9K sh	—	—	0
2014-01-09	CBIOCRESCENT BIOPHARMA, INC. · Stock Option (right to buy)A Award	SVP of Research, CSO	AAward	+169K sh	—	—	169,038

Recent filings

Accepted (ET)
Nov 144
Magnani John L.0001209191-22-056573
SEC(opens sec.gov)
Mar 104
Magnani John L.0001209191-22-017977
SEC(opens sec.gov)
Jan 254
Magnani John L.0001209191-22-004893
SEC(opens sec.gov)
Jan 224
Magnani John L.0001209191-21-004840
SEC(opens sec.gov)
Jan 244
Magnani John L.0001209191-20-004826
SEC(opens sec.gov)
Jan 64
Magnani John L.0001209191-20-002098
SEC(opens sec.gov)
Dec 234
Magnani John L.0001209191-19-061782
SEC(opens sec.gov)
Jan 224
Magnani John L.0001209191-19-004825
SEC(opens sec.gov)
Oct 184
Magnani John L.0001209191-18-055586
SEC(opens sec.gov)
May 244
Magnani John L.0001209191-18-033068
SEC(opens sec.gov)
May 114
GLYCOMIMETICS INC0001209191-17-031515
SEC(opens sec.gov)

Companies

CRESCENT BIOPHARMA, INC.SVP of Research, CSOCBIO

Address

C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250

GAITHERSBURG, MD, 20879